Eli Lilly Raises 2016 Profit Forecast After Tax Benefit

  • Drugmaker says earnings will be $3.50 to $3.60 a share in 2016
  • First-quarter profit declined to 83 cents; estimate 85 cents

Lilly CEO: On Track to Hit 2018 Operating Expense Goal

Eli Lilly & Co. raised its profit and sales forecasts for the year after receiving a tax benefit in the first quarter.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.